1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine

C162H270F3N27O6 — CID 158681154

IUPAC1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine
SMILESCC(C)(C)CC1(CN2CCCC2)CC1.CC(C)(C)CC1(CN2CCOCC2)CC1.CC(C)(C)CC1(Cn2ccnc2)CC1.CC(C)(C)CCn1ccc(C(F)(F)F)n1.CC(C)(C)CCn1cccn1.CC(C)(C)Cn1nc2ccccc2n1.CC(C)(C)Cn1nnnc1-c1ccccc1.CC(C)(C)OCc1cccnc1.CC(C)(C)OCc1ncccn1.CCOC(=O)N1CCC(=O)C(C(C)(C)C)C1.CCc1nccn1CC1(CC(C)(C)C)CC1.Cc1cc(C)n(CC2(CC(C)(C)C)CC2)n1.Cc1ccn(CCC(C)(C)C)n1.Cc1nccn1CC1(CC(C)(C)C)CC1
InChIInChI=1S/2C14H24N2.C13H22N2.C13H25NO.C13H25N.C12H16N4.C12H20N2.C12H21NO3.C11H15N3.C10H15F3N2.C10H18N2.C10H15NO.C9H14N2O.C9H16N2/c1-11-8-12(2)16(15-11)10-14(6-7-14)9-13(3,4)5;1-5-12-15-8-9-16(12)11-14(6-7-14)10-13(2,3)4;1-11-14-7-8-15(11)10-13(5-6-13)9-12(2,3)4;1-12(2,3)10-13(4-5-13)11-14-6-8-15-9-7-14;1-12(2,3)10-13(6-7-13)11-14-8-4-5-9-14;1-12(2,3)9-16-11(13-14-15-16)10-7-5-4-6-8-10;1-11(2,3)8-12(4-5-12)9-14-7-6-13-10-14;1-5-16-11(15)13-7-6-10(14)9(8-13)12(2,3)4;1-11(2,3)8-14-12-9-6-4-5-7-10(9)13-14;1-9(2,3)5-7-15-6-4-8(14-15)10(11,12)13;1-9-5-7-12(11-9)8-6-10(2,3)4;1-10(2,3)12-8-9-5-4-6-11-7-9;1-9(2,3)12-7-8-10-5-4-6-11-8;1-9(2,3)5-8-11-7-4-6-10-11/h8H,6-7,9-10H2,1-5H3;8-9H,5-7,10-11H2,1-4H3;7-8H,5-6,9-10H2,1-4H3;4-11H2,1-3H3;4-11H2,1-3H3;4-8H,9H2,1-3H3;6-7,10H,4-5,8-9H2,1-3H3;9H,5-8H2,1-4H3;4-7H,8H2,1-3H3;4,6H,5,7H2,1-3H3;5,7H,6,8H2,1-4H3;4-7H,8H2,1-3H3;4-6H,7H2,1-3H3;4,6-7H,5,8H2,1-3H3
InChIKeyIFDKLZCHQPIRMS-UHFFFAOYSA-N
MW2749.12 g/mol
LogP39.14
Rot. Bonds33

About 1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine

1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine (PubChem CID 158681154) has the molecular formula C162H270F3N27O6 and a molecular weight of 2749.12 g/mol. Its IUPAC name is 1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine.

Molecular Properties

Compound Name1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine
PubChem CID158681154
Molecular FormulaC162H270F3N27O6
Molecular Weight2749.12 g/mol
Exact Mass2747.16
IUPAC Name1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine
SMILESCC(C)(C)CC1(CN2CCCC2)CC1.CC(C)(C)CC1(CN2CCOCC2)CC1.CC(C)(C)CC1(Cn2ccnc2)CC1.CC(C)(C)CCn1ccc(C(F)(F)F)n1.CC(C)(C)CCn1cccn1.CC(C)(C)Cn1nc2ccccc2n1.CC(C)(C)Cn1nnnc1-c1ccccc1.CC(C)(C)OCc1cccnc1.CC(C)(C)OCc1ncccn1.CCOC(=O)N1CCC(=O)C(C(C)(C)C)C1.CCc1nccn1CC1(CC(C)(C)C)CC1.Cc1cc(C)n(CC2(CC(C)(C)C)CC2)n1.Cc1ccn(CCC(C)(C)C)n1.Cc1nccn1CC1(CC(C)(C)C)CC1
InChIInChI=1S/2C14H24N2.C13H22N2.C13H25NO.C13H25N.C12H16N4.C12H20N2.C12H21NO3.C11H15N3.C10H15F3N2.C10H18N2.C10H15NO.C9H14N2O.C9H16N2/c1-11-8-12(2)16(15-11)10-14(6-7-14)9-13(3,4)5;1-5-12-15-8-9-16(12)11-14(6-7-14)10-13(2,3)4;1-11-14-7-8-15(11)10-13(5-6-13)9-12(2,3)4;1-12(2,3)10-13(4-5-13)11-14-6-8-15-9-7-14;1-12(2,3)10-13(6-7-13)11-14-8-4-5-9-14;1-12(2,3)9-16-11(13-14-15-16)10-7-5-4-6-8-10;1-11(2,3)8-12(4-5-12)9-14-7-6-13-10-14;1-5-16-11(15)13-7-6-10(14)9(8-13)12(2,3)4;1-11(2,3)8-14-12-9-6-4-5-7-10(9)13-14;1-9(2,3)5-7-15-6-4-8(14-15)10(11,12)13;1-9-5-7-12(11-9)8-6-10(2,3)4;1-10(2,3)12-8-9-5-4-6-11-7-9;1-9(2,3)12-7-8-10-5-4-6-11-8;1-9(2,3)5-8-11-7-4-6-10-11/h8H,6-7,9-10H2,1-5H3;8-9H,5-7,10-11H2,1-4H3;7-8H,5-6,9-10H2,1-4H3;4-11H2,1-3H3;4-11H2,1-3H3;4-8H,9H2,1-3H3;6-7,10H,4-5,8-9H2,1-3H3;9H,5-8H2,1-4H3;4-7H,8H2,1-3H3;4,6H,5,7H2,1-3H3;5,7H,6,8H2,1-4H3;4-7H,8H2,1-3H3;4-6H,7H2,1-3H3;4,6-7H,5,8H2,1-3H3
InChIKeyIFDKLZCHQPIRMS-UHFFFAOYSA-N
XLogP39.14
TPSA318.50 Ų
H-Bond Donors
H-Bond Acceptors32
Rotatable Bonds33
Heavy Atoms198
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002749.12
LogP ≤ 539.14
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1032

Analyze 1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine?
The IUPAC name of 1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine (CID 158681154) is 1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine.
What is the SMILES notation for 1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine?
The canonical SMILES for 1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine is CC(C)(C)CC1(CN2CCCC2)CC1.CC(C)(C)CC1(CN2CCOCC2)CC1.CC(C)(C)CC1(Cn2ccnc2)CC1.CC(C)(C)CCn1ccc(C(F)(F)F)n1.CC(C)(C)CCn1cccn1.CC(C)(C)Cn1nc2ccccc2n1.CC(C)(C)Cn1nnnc1-c1ccccc1.CC(C)(C)OCc1cccnc1.CC(C)(C)OCc1ncccn1.CCOC(=O)N1CCC(=O)C(C(C)(C)C)C1.CCc1nccn1CC1(CC(C)(C)C)CC1.Cc1cc(C)n(CC2(CC(C)(C)C)CC2)n1.Cc1ccn(CCC(C)(C)C)n1.Cc1nccn1CC1(CC(C)(C)C)CC1.
What is the InChIKey of 1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine?
The InChIKey is IFDKLZCHQPIRMS-UHFFFAOYSA-N. The full InChI is InChI=1S/2C14H24N2.C13H22N2.C13H25NO.C13H25N.C12H16N4.C12H20N2.C12H21NO3.C11H15N3.C10H15F3N2.C10H18N2.C10H15NO.C9H14N2O.C9H16N2/c1-11-8-12(2)16(15-11)10-14(6-7-14)9-13(3,4)5;1-5-12-15-8-9-16(12)11-14(6-7-14)10-13(2,3)4;1-11-14-7-8-15(11)10-13(5-6-13)9-12(2,3)4;1-12(2,3)10-13(4-5-13)11-14-6-8-15-9-7-14;1-12(2,3)10-13(6-7-13)11-14-8-4-5-9-14;1-12(2,3)9-16-11(13-14-15-16)10-7-5-4-6-8-10;1-11(2,3)8-12(4-5-12)9-14-7-6-13-10-14;1-5-16-11(15)13-7-6-10(14)9(8-13)12(2,3)4;1-11(2,3)8-14-12-9-6-4-5-7-10(9)13-14;1-9(2,3)5-7-15-6-4-8(14-15)10(11,12)13;1-9-5-7-12(11-9)8-6-10(2,3)4;1-10(2,3)12-8-9-5-4-6-11-7-9;1-9(2,3)12-7-8-10-5-4-6-11-8;1-9(2,3)5-8-11-7-4-6-10-11/h8H,6-7,9-10H2,1-5H3;8-9H,5-7,10-11H2,1-4H3;7-8H,5-6,9-10H2,1-4H3;4-11H2,1-3H3;4-11H2,1-3H3;4-8H,9H2,1-3H3;6-7,10H,4-5,8-9H2,1-3H3;9H,5-8H2,1-4H3;4-7H,8H2,1-3H3;4,6H,5,7H2,1-3H3;5,7H,6,8H2,1-4H3;4-7H,8H2,1-3H3;4-6H,7H2,1-3H3;4,6-7H,5,8H2,1-3H3.
What are the key properties of 1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine?
1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine has a molecular weight of 2749.12 g/mol, XLogP of 39.14, 33 rotatable bonds, 0 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(3,3-dimethylbutyl)-3-methylpyrazole;1-(3,3-dimethylbutyl)pyrazole;1-(3,3-dimethylbutyl)-3-(trifluoromethyl)pyrazole;2-(2,2-dimethylpropyl)benzotriazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-3,5-dimethylpyrazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-ethylimidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]imidazole;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]-2-methylimidazole;4-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]morpholine;1-[[1-(2,2-dimethylpropyl)cyclopropyl]methyl]pyrrolidine;1-(2,2-dimethylpropyl)-5-phenyltetrazole;ethyl 3-tert-butyl-4-oxopiperidine-1-carboxylate;3-[(2-methylpropan-2-yl)oxymethyl]pyridine;2-[(2-methylpropan-2-yl)oxymethyl]pyrimidine is sourced from PubChem (CID 158681154), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).